MyFinsight
Home
About
Contact
Download
Download image
Net (loss) income
-$200M
(-1638.46%↓ Y/Y)
Gross product sales
$1,971M
Provision for income taxes
$13M
(62.50%↑ Y/Y)
(loss) income before
income taxes
-$187M
(-990.48%↓ Y/Y)
Interest income
$73M
(-29.13%↓ Y/Y)
Product And Service
Other
$43M
(2.38%↑ Y/Y)
Product Sales
$973M
(-46.54%↓ Y/Y)
Total product sales
provision
-$998M
Loss from operations
-$260M
(-271.43%↓ Y/Y)
Total revenue
$1,016M
(-45.44%↓ Y/Y)
Returns, rebates and
other fees
-$236M
Wholesaler chargebacks,
discounts and fees
-$762M
Total operating
expenses
$1,276M
(-33.95%↓ Y/Y)
Selling, general and
administrative
$268M
(-4.63%↓ Y/Y)
Research and development
$801M
(-29.55%↓ Y/Y)
Cost of sales
$207M
(-59.73%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
mrna: the income statement
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)